会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Benzazepine derivatives
    • 苯扎西平衍生物
    • US4604389A
    • 1986-08-05
    • US732204
    • 1985-05-08
    • Manfred ReiffenKlaus NollJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • Manfred ReiffenKlaus NollJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • A61K31/55A61P9/06C07C59/64C07D223/16C07D233/16C07D243/04C07D405/12C07D491/04C07D491/056C07D521/00
    • C07D223/16C07C59/64C07D243/04C07D405/12C07D491/04
    • This invention relates to benzazepine derivatives of formula I ##STR1## wherein A is --CH.sub.2 CH.sub.2 -- or --CH.dbd.CH--;R.sub.1 is hydrogen, chlorine, bromine, C.sub.1 -C.sub.3 alkyl, amino, C.sub.1 -C.sub.3 alkylamino, C.sub.1 -C.sub.3 dialkylamino, acylamino, hydroxy, C.sub.1 -C.sub.3 alkoxy or phenyl C.sub.1 -C.sub.3 alkoxy;R.sub.2 is hydrogen, chlorine, bromine, hydroxy, C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy or phenyl C.sub.1 -C.sub.3 alkoxy or, together with R.sub.1, can be C.sub.1 -C.sub.3 alkylenedioxy;R.sub.3 is hydrogen, chlorine, bromine or C.sub.1 -C.sub.3 alkoxy;R.sub.4 is hydrogen, benzyl, C.sub.1 -C.sub.3 alkyl or C.sub.3 -C.sub.5 alkenyl;R.sub.5 is hydrogen, halogen, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy;R.sub.6 is hydrogen, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy or, together with R.sub.5, can be a C.sub.1 -C.sub.2 alkylenedioxy;X is an imino, optionally substituted by a benzyl or C.sub.1 -C.sub.3 alkyl, or is oxygen, sulphur, sulphinyl or sulphonyl;Y is an imino, optionally substituted by a benzyl or C.sub.1 -C.sub.3 alkyl, or is methylene or carbonyl;m and n are each independently 2, 3 or 4; and nontoxic, pharmaceutically acceptable addition salts thereof. These compounds have valuable pharmacological properties, particularly the effect of lowering heart rate and reducing the O.sub.2 requirement of the heart.
    • 本发明涉及式I的苯并氮杂衍生物,其中A是-CH 2 CH 2 - 或-CH = CH-; R1是氢,氯,溴,C1-C3烷基,氨基,C1-C3烷基氨基,C1-C3二烷基氨基,酰氨基,羟基,C1-C3烷氧基或苯基C1-C3烷氧基; R2是氢,氯,溴,羟基,C1-C3烷基,C1-C3烷氧基或苯基C1-C3烷氧基,或与R1一起可以是C1-C3亚烷基二氧基; R3是氢,氯,溴或C1-C3烷氧基; R4是氢,苄基,C1-C3烷基或C3-C5烯基; R5是氢,卤素,C1-C3烷基或C1-C3烷氧基; R 6是氢,C 1 -C 3烷基或C 1 -C 3烷氧基,或与R 5一起可以是C 1 -C 2亚烷基二氧基; X是任选被苄基或C 1 -C 3烷基取代的亚氨基,或是氧,硫,亚磺酰基或磺酰基; Y是任选被苄基或C 1 -C 3烷基取代的亚氨基,或亚甲基或羰基; m和n各自独立地为2,3或4; 和无毒的药学上可接受的加成盐。 这些化合物具有有价值的药理学特性,特别是降低心率并降低心脏O2需求的作用。
    • 8. 发明授权
    • Novel indole derivatives and pharmaceutical compositions containing same
    • 新型吲哚衍生物和含有它们的药物组合物
    • US4616011A
    • 1986-10-07
    • US675084
    • 1984-11-26
    • Manfred ReiffenJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • Manfred ReiffenJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • A61K31/55A61P9/06A61P9/08A61P9/10A61P25/02C07C59/64C07D209/14C07D209/16C07D209/18C07D223/16C07D403/12C07D405/14
    • C07D223/16C07C59/64C07D209/16C07D209/18C07D403/12
    • This invention relates to novel indole derivatives of the formula ##STR1## wherein A represents a --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--, ##STR2## group and B represents a methylene, carbonyl, or thiocarbonyl group or A represents a --CO--CO-- or ##STR3## group and B represents a methylene group, E represents an alkylene group or a 2-hydroxy-n-propylene, 2-hydroxy-n-butylene, or 3-hydroxy-n-butylene group,G represents an alkylene group,R.sub.1 represents a hydrogen, chlorine, or bromine atom or a trifluoromethyl, nitro, amino, alkylamino, dialkylamino, alkyl, hydroxyl, alkoxy, or phenylalkoxy group,R.sub.2 represents a hydrogen, chlorine, or bromine atom or a hydroxyl, alkoxy, phenylalkoxy, or alkyl group orR.sub.1 and R.sub.2 together represent an alkylenedioxy group,R.sub.3 represents a hydrogen, chlorine, or bromine atom or an alkyl group,R.sub.4 represents a hydrogen atom or an alkyl or phenylalkyl group,R.sub.5 represents a hydrogen, fluorine, chlorine, or bromine atom or an alkyl, hydroxyl, alkoxy, or phenylalkoxy group,R.sub.6 represents a hydrogen atom or an alkoxy group, andR.sub.7 represents a hydrogen atom or an alkenyl, alkyl or phenylalkyl group,and the acid additional salts thereof. These compounds, which may be obtained by use of known methods, have valuable pharmacological properties, particularly a heart rate-lowering activity.
    • 本发明涉及式(I)的新的吲哚衍生物,其中A代表-CH2-CH2-,-CH = CH-,IMA组,B代表亚甲基,羰基或硫代羰基,或A代表 -CO-CO-或基,B表示亚甲基,E表示亚烷基或2-羟基正丙烯,2-羟基 - 正丁烯或3-羟基 - 正丁烯基 ,G表示亚烷基,R 1表示氢,氯或溴原子或三氟甲基,硝基,氨基,烷基氨基,二烷基氨基,烷基,羟基,烷氧基或苯基烷氧基,R 2表示氢,氯或溴原子或 羟基,烷氧基,苯基烷氧基或烷基,或者R 1和R 2一起表示亚烷基二氧基,R 3表示氢,氯或溴原子或烷基,R 4表示氢原子或烷基或苯基烷基,R 5表示 氢,氟,氯或溴原子或烷基,羟基,烷氧基或苯基烷氧基,R6代表 氢原子或烷氧基,R7表示氢原子或烯基,烷基或苯基烷基,及其酸加成盐。 可以通过使用已知方法获得的这些化合物具有有价值的药理学性质,特别是心率降低活性。
    • 9. 发明授权
    • Aminotetralin derivatives
    • 氨基四氢萘衍生物
    • US4584293A
    • 1986-04-22
    • US732199
    • 1985-05-08
    • Manfred ReiffenJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • Manfred ReiffenJoachim HeiderVolkhard AustelNorbert HauelWalter KobingerChristian Lillie
    • A61K31/55A61P9/06A61P9/08A61P9/10C07C45/00C07C45/51C07C49/755C07C57/58C07C59/64C07C205/56C07D223/16C07D243/04C07D491/056C07D521/00
    • C07D223/16C07C205/56C07C45/00C07C45/513C07C49/755C07C57/58C07C59/64C07D231/12C07D233/56C07D243/04C07D249/08
    • This invention related to new aminotetralin derivatives of formula I ##STR1## wherein ##STR2## B is methylene or, when A is --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--, --NH--CO-- or --CH.sub.2 --CO--, B can also be carbonyl or thiocarbonyl;E is a C.sub.2 -C.sub.4 straight-chain alkylene, optionally substituted by a C.sub.1 -C.sub.3 alkyl, or is 2-hydroxy-n-propylene, 2-hydroxy-n-butylene or 3-hydroxy-n-butylene;R.sub.1 is hydrogen, fluorine, chlorine, bromine, trifluoromethyl, nitro, amino, C.sub.1 -C.sub.3 alkylamino, C.sub.1 -C.sub.3 dialkylamino, C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkylthio, hydroxy, C.sub.1 -C.sub.3 alkoxy or phenyl C.sub.1 -C.sub.3 alkoxy;R.sub.2 is hydrogen, chlorine, bromine, hydroxy, C.sub.1 -C.sub.3 alkoxy phenyl C.sub.1 -C.sub.3 alkoxy, or C.sub.1 -C.sub.3 alkyl or, together with R.sub.1, can be a C.sub.1 -C.sub.2 alkylenedioxy;R.sub.3 and R.sub.4 are each independently selected from hydrogen, fluorine, chlorine, bromine, C.sub.1 -C.sub.3 alkyl, hydroxy, C.sub.1 -C.sub.3 alkoxy, nitro, amino, C.sub.1 -C.sub.3 alkylamino, or C.sub.1 -C.sub.3 dialkylamino, or together can be methylenedioxy; andR.sub.5 is hydrogen, C.sub.3 -C.sub.5 alkenyl, C.sub.1 -C.sub.3 alkyl, or phenyl C.sub.1 -C.sub.3 alkyl, and nontoxic, pharmaceutically acceptable addition salts thereof which have valuable pharmacological properties, particularly a long-lasting heart rate lowering effect and the effect of reducing the O.sub.2 requirement of the heart.
    • 本发明涉及新的式I的氨基蝶呤衍生物,其中B是亚甲基,或当A是-CH 2 -CH 2 - 时,-CH = CH-,-NH-CO-或-CH 2 -CO-,B也可以是羰基或硫代羰基; E是任选被C 1 -C 3烷基取代的C 2 -C 4直链亚烷基,或是2-羟基 - 正丙烯,2-羟基 - 正丁烯或3-羟基 - 正丁烯; R1是氢,氟,氯,溴,三氟甲基,硝基,氨基,C1-C3烷基氨基,C1-C3二烷基氨基,C1-C3烷基,C1-C3烷硫基,羟基,C1-C3烷氧基或苯基C1-C3烷氧基; R2是氢,氯,溴,羟基,C1-C3烷氧基苯基C1-C3烷氧基或C1-C3烷基,或与R1一起可以是C1-C2亚烷基二氧基; R 3和R 4各自独立地选自氢,氟,氯,溴,C 1 -C 3烷基,羟基,C 1 -C 3烷氧基,硝基,氨基,C 1 -C 3烷基氨基或C 1 -C 3二烷基氨基,或一起可以是亚甲二氧基; 并且R 5是氢,C 3 -C 5烯基,C 1 -C 3烷基或苯基C 1 -C 3烷基,以及其无毒的药学上可接受的加成盐,其具有有价值的药理学性质,特别是持久的心率降低效果和降低 心脏的O2要求。